REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical CO LTD
RNS Number : 2072JSociete Generale SA03 December 2018FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Takeda Pharmaceutical CO LTD
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
30/11/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES: Shire PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
1,956,142
0.25
7,777,344
0.99
(2) Cash-settled derivatives:
6,898,733
0.88
0
0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
121,500
0.02
256,000
0.03
TOTAL:
8,976,375
1.14
8,033,344
1.02
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit
JPY
Ordinary
Purchase
1,000
4194.5
Ordinary
Purchase
400
4126.5
Ordinary
Purchase
100
4136.5
Ordinary
Purchase
100
4136.5
Ordinary
Purchase
100
4153
Ordinary
Purchase
100
4153
Ordinary
Purchase
100
4155
Ordinary
Purchase
600
4157
Ordinary
Purchase
400
4160.5
Ordinary
Purchase
1,400
4154
Ordinary
Purchase
200
4152
Ordinary
Purchase
200
4158.5
Ordinary
Purchase
100
4156.5
Ordinary
Purchase
100
4156.5
Ordinary
Purchase
400
4158
Ordinary
Purchase
700
4160.5
Ordinary
Purchase
8,700
4255
Ordinary
Purchase
400
4187
Ordinary
Purchase
1,200
4207
Ordinary
Purchase
600
4214
Ordinary
Purchase
2,100
4201
Ordinary
Purchase
1,500
4194
Ordinary
Purchase
100
4214
Ordinary
Purchase
1,600
4196
Ordinary
Purchase
100
4124
Ordinary
Purchase
1,400
4128
Ordinary
Purchase
200
4127
Ordinary
Purchase
100
4220
Ordinary
Purchase
500
4221
Ordinary
Purchase
600
4138
Ordinary
Purchase
1,900
4220
Ordinary
Purchase
600
4137
Ordinary
Purchase
400
4126
Ordinary
Purchase
1,200
4195
Ordinary
Purchase
500
4128
Ordinary
Purchase
300
4223
Ordinary
Purchase
1,200
4129
Ordinary
Purchase
700
4129
Ordinary
Purchase
100
4195
Ordinary
Purchase
100
4210
Ordinary
Purchase
900
4210
Ordinary
Purchase
400
4209
Ordinary
Purchase
100
4196
Ordinary
Purchase
500
4207
Ordinary
Purchase
400
4204
Ordinary
Purchase
100
4195
Ordinary
Purchase
1,900
4198
Ordinary
Purchase
100
4193
Ordinary
Purchase
400
4203
Ordinary
Purchase
2,400
4194
Ordinary
Purchase
100
4214
Ordinary
Purchase
100
4213
Ordinary
Purchase
2,400
4210
Ordinary
Purchase
1,400
4153
Ordinary
Purchase
900
4152
Ordinary
Purchase
600
4162
Ordinary
Purchase
1,700
4223
Ordinary
Purchase
100
4227
Ordinary
Purchase
1,600
4200
Ordinary
Purchase
400
4192
Ordinary
Purchase
2,400
4201
Ordinary
Purchase
2,200
4217
Ordinary
Purchase
400
4214
Ordinary
Purchase
2,400
4209
Ordinary
Purchase
1,100
4231
Ordinary
Purchase
100
4196
Ordinary
Purchase
200
4213
Ordinary
Purchase
700
4217
Ordinary
Purchase
1,400
4199
Ordinary
Purchase
100
4227
Ordinary
Purchase
300
4129
Ordinary
Purchase
300
4120
Ordinary
Purchase
1,000
4206
Ordinary
Purchase
500
4208
Ordinary
Purchase
2,200
4123
Ordinary
Purchase
300
4136
Ordinary
Purchase
600
4137
Ordinary
Purchase
200
4127
Ordinary
Purchase
100
4129
Ordinary
Purchase
1,100
4119
Ordinary
Purchase
1,000
4210
Ordinary
Purchase
300
4116
Ordinary
Purchase
1,100
4117
Ordinary
Purchase
600
4118
Ordinary
Purchase
700
4118
Ordinary
Purchase
1,100
4120
Ordinary
Purchase
1,100
4153
Ordinary
Purchase
1,000
4203
Ordinary
Purchase
200
4189
Ordinary
Purchase
1,000
4186
Ordinary
Purchase
1,000
4206
Ordinary
Purchase
2,300
4234
Ordinary
Purchase
2,900
4255
Ordinary
Purchase
700
4209
Ordinary
Purchase
600
4213
Ordinary
Purchase
700
4211
Ordinary
Purchase
700
4213
Ordinary
Purchase
600
4214
Ordinary
Purchase
600
4207
Ordinary
Purchase
500
4215
Ordinary
Purchase
100
4214
Ordinary
Purchase
500
4211
Ordinary
Purchase
600
4212
Ordinary
Purchase
6,200
4255
Ordinary
Purchase
200
4255
Ordinary
Purchase
200
4205
Ordinary
Purchase
200
4216
Ordinary
Purchase
200
4191
Ordinary
Purchase
200
4213
Ordinary
Purchase
200
4198
Ordinary
Purchase
200
4209
Ordinary
Purchase
200
4194
Ordinary
Purchase
200
4201
Ordinary
Purchase
200
4197
Ordinary
Purchase
200
4204
Ordinary
Purchase
200
4199
Ordinary
Purchase
200
4205
Ordinary
Purchase
300
4157
Ordinary
Purchase
200
4196
Ordinary
Purchase
200
4227
Ordinary
Purchase
200
4211
Ordinary
Purchase
200
4231
Ordinary
Purchase
200
4178
Ordinary
Purchase
300
4255
Ordinary
Purchase
5,900
4213.939115
Ordinary
Purchase
85
4160
Ordinary
Sale
100
4225
Ordinary
Sale
200
4197
Ordinary
Sale
100
4208.5
Ordinary
Sale
100
4208.5
Ordinary
Sale
100
4213
Ordinary
Sale
100
4213
Ordinary
Sale
500
4213
Ordinary
Sale
200
4201.5
Ordinary
Sale
400
4129
Ordinary
Sale
100
4201.5
Ordinary
Sale
200
4202.5
Ordinary
Sale
300
4173.5
Ordinary
Sale
100
4217
Ordinary
Sale
1,400
4209
Ordinary
Sale
1,400
4218
Ordinary
Sale
800
4202
Ordinary
Sale
500
4119
Ordinary
Sale
1,400
4116
Ordinary
Sale
300
4130
Ordinary
Sale
1,000
4224
Ordinary
Sale
200
4226
Ordinary
Sale
700
4256
Ordinary
Sale
100
4125
Ordinary
Sale
100
4118
Ordinary
Sale
300
4118
Ordinary
Sale
1,100
4118
Ordinary
Sale
1,400
4119
Ordinary
Sale
300
4159
Ordinary
Sale
500
4158
Ordinary
Sale
200
4168
Ordinary
Sale
100
4160
Ordinary
Sale
200
4162
Ordinary
Sale
1,000
4158
Ordinary
Sale
200
4200
Ordinary
Sale
500
4199
Ordinary
Sale
1,100
4159
Ordinary
Sale
100
4157
Ordinary
Sale
100
4174
Ordinary
Sale
100
4178
Ordinary
Sale
500
4177
Ordinary
Sale
700
4169
Ordinary
Sale
400
4184
Ordinary
Sale
800
4185
Ordinary
Sale
1,300
4211
Ordinary
Sale
1,400
4194
Ordinary
Sale
1,500
4178
Ordinary
Sale
300
4208
Ordinary
Sale
300
4116
Ordinary
Sale
300
4114
Ordinary
Sale
300
4116
Ordinary
Sale
300
4157
Ordinary
Sale
1,000
4197
Ordinary
Sale
600
4229
Ordinary
Sale
500
4224
Ordinary
Sale
1,000
4200
Ordinary
Sale
100
4229
Ordinary
Sale
700
4217
Ordinary
Sale
800
4196
Ordinary
Sale
1,800
4196
Ordinary
Sale
2,000
4198
Ordinary
Sale
100
4231
Ordinary
Sale
800
4218
Ordinary
Sale
200
4119
Ordinary
Sale
500
4221
Ordinary
Sale
200
4117
Ordinary
Sale
1,100
4116
Ordinary
Sale
1,000
4204
Ordinary
Sale
500
4224
Ordinary
Sale
100
4116
Ordinary
Sale
1,000
4201
Ordinary
Sale
1,000
4194
Ordinary
Sale
1,000
4128
Ordinary
Sale
200
4159
Ordinary
Sale
100
4159
Ordinary
Sale
500
4158
Ordinary
Sale
800
4160
Ordinary
Sale
1,100
4163
Ordinary
Sale
700
4195
Ordinary
Sale
700
4158
Ordinary
Sale
100
4150
Ordinary
Sale
100
4150
Ordinary
Sale
1,100
4159
Ordinary
Sale
1,000
4221
Ordinary
Sale
100
4158
Ordinary
Sale
800
4158
Ordinary
Sale
500
4156
Ordinary
Sale
500
4198
Ordinary
Sale
1,200
4203
Ordinary
Sale
900
4199
Ordinary
Sale
300
4166
Ordinary
Sale
1,100
4165
Ordinary
Sale
1,000
4210
Ordinary
Sale
100
4177
Ordinary
Sale
700
4176
Ordinary
Sale
800
4227
Ordinary
Sale
2,000
4197
Ordinary
Sale
1,000
4207
Ordinary
Sale
500
4199
Ordinary
Sale
600
4199
Ordinary
Sale
600
4217
Ordinary
Sale
1,000
4202
Ordinary
Sale
100
4233
Ordinary
Sale
400
4233
Ordinary
Sale
1,000
4232
Ordinary
Sale
900
4217
Ordinary
Sale
1,000
4197
Ordinary
Sale
200
4233
Ordinary
Sale
6,300
4255
Ordinary
Sale
700
4222
Ordinary
Sale
600
4220
Ordinary
Sale
300
4199
Ordinary
Sale
700
4208
Ordinary
Sale
800
4209
Ordinary
Sale
400
4210
Ordinary
Sale
400
4211
Ordinary
Sale
400
4211
Ordinary
Sale
400
4212
Ordinary
Sale
600
4162
Ordinary
Sale
500
4160
Ordinary
Sale
400
4160
Ordinary
Sale
400
4165
Ordinary
Sale
400
4167
Ordinary
Sale
300
4180
Ordinary
Sale
100
4205
Ordinary
Sale
100
4209
Ordinary
Sale
5,600
4255
Ordinary
Sale
300
4255
Ordinary
Sale
720
3707.4648
Ordinary
Sale
85
4236
Ordinary
Sale
85
4124
Total Purchases
102,485
Total Sales
85,990
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit JPY
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit JPY
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit JPY
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable) JPY
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
YES
Date of disclosure:
03/12/2018
Contact name:
Olivier Vero
Telephone number:
+44 20 7676 6969
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure:
SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:
Takeda Pharmaceutical CO LTD
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of relevant security
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
Expiry date
JPY
e.g. American, European etc.
Ordinary
OTC put-option
Sale
15,700
4707
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,000
5075.10
European options
14/12/2018
Ordinary
OTC put-option
Sale
29,600
5073.65
European options
14/12/2018
Ordinary
OTC put-option
Sale
15,500
4491.40
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,700
4533.90
European options
14/12/2018
Ordinary
Listed call-option
Sale
125,000
5500
European options
13/06/2019
Ordinary
OTC call-option
Sale
131,000
4,600
European options
13/12/2018
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETUGGUCPUPRUBW
Recent news on Takeda Pharmaceutical Co
See all newsREG - Malin Corp PLC - Malin Announces 2021 Full Year Results
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements
AnnouncementREG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate
AnnouncementREG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda
Announcement